|
Market Closed -
Warsaw S.E.
20:04:56 12/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 5.490 PLN | +0.73% |
|
-1.44% | -16.82% |
Company Valuation: Molecure S.A.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 200.1 | 328.3 | 170 | 113.1 | 113.1 | - |
| Change | - | 64.1% | -48.21% | -33.48% | 0% | - |
| Enterprise Value (EV) 1 | 200.1 | 271.5 | 159.1 | 124.9 | 117 | 112.1 |
| Change | - | 35.68% | -41.39% | -21.47% | 42.33% | -4.19% |
| P/E | -13.1x | -17.9x | -6.52x | - | -9.15x | -54.9x |
| PBR | - | 2.09x | 1.97x | - | 1.1x | 1.37x |
| PEG | - | - | -0.2x | - | - | 0.7x |
| Capitalization / Revenue | - | 247x | 58x | 20.9x | 15.6x | 6.34x |
| EV / Revenue | - | 204x | 54.2x | 19.2x | 16.1x | 6.28x |
| EV / EBITDA | - | -13.4x | -5.59x | -9.22x | -3.9x | -21.2x |
| EV / EBIT | - | -12.3x | -4.93x | -7.54x | -3.57x | -14.5x |
| EV / FCF | - | - | - | - | -3,545,798x | -112,111,320x |
| FCF Yield | - | - | - | - | -0% | -0% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -1.09 | -1.09 | -1.55 | - | -0.6 | -0.1 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | - | 1.328 | 2.934 | 6.519 | 7.267 | 17.85 |
| EBITDA 1 | - | -20.26 | -28.48 | -13.55 | -30 | -5.3 |
| EBIT 1 | - | -22.1 | -32.3 | -16.56 | -32.77 | -7.75 |
| Net income 1 | -15.26 | -18.31 | -31.29 | -15.69 | -32.97 | -8.35 |
| Net Debt 1 | - | -56.85 | -10.96 | -11.06 | 3.9 | -1 |
| Reference price 2 | 14.260 | 19.500 | 10.100 | 5.490 | 5.490 | 5.490 |
| Nbr of stocks (in thousands) | 14,030 | 16,836 | 16,836 | 20,603 | 20,603 | - |
| Announcement Date | 30/03/23 | 17/05/24 | 27/03/25 | 10/03/26 | - | - |
1PLN in Million2PLN
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 21.08x | -4.64x | - | 28.44M | |
| 17.64x | 6.77x | 12.98x | 1.69% | 67.53B | |
| 32.85x | 8.79x | 29.04x | 0.07% | 60.74B | |
| 38.46x | 6.84x | 20.46x | 0.85% | 55.66B | |
| 46.76x | 6.33x | 30.27x | -.--% | 47.97B | |
| 35.83x | 3.38x | 14.58x | -.--% | 45.24B | |
| -21.57x | 57.33x | -23.69x | -.--% | 39.08B | |
| 35.06x | 8.67x | 22.58x | 0.37% | 35.34B | |
| 41.53x | 8.15x | 27.06x | -.--% | 33.45B | |
| -73.68x | 13.96x | -75.03x | -.--% | 26.49B | |
| Average | 16.98x | 14.13x | 5.36x | 0.33% | 41B | |
| Weighted average by Cap. | 21.93x | 12.19x | 11.37x | 0.43% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- MOC Stock
- Valuation Molecure S.A.
Select your edition
All financial news and data tailored to specific country editions
